p300/CBP as a vital transcriptional co-activator and HAT contributes to a variety of cellular activities and plays a role in immune-mediated diseases and cancers through chromatin remodeling and gene activation (Karamouzis et al., 2007; Dancy and Cole, 2015). Here, EP300 is linked to cancer.